Gerard Vockley, MD, Medical Genetics, Pittsburgh, PA, UPMC Magee-Womens Hospital


Medical Genetics Pittsburgh, PA

Clinical Biochemical/Molecular Genetics, Clinical Genetics

Professor, Pediatrics and Human Genetics, University of Pittsburgh School of Medicine

Dr. Vockley is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Vockley's full profile

Already have an account?

Education & Training

  • Yale University School of Medicine
    Yale University School of MedicineFellowship, Medical Genetics, 1987 - 1991
  • University of Colorado
    University of ColoradoResidency, Pediatrics, 1984 - 1986
  • University of PennsylvaniaPh.D., Genetics, 1978 - 1984
  • Perelman School of Medicine at the University of Pennsylvania
    Perelman School of Medicine at the University of PennsylvaniaClass of 1984
  • Carnegie Mellon UniversityBS, Biology, University Honors, 1974 - 1978
  • Carnegie Mellon UniversityB.S., Biology, With university honors, 1974 - 1978

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 2003 - 2022
  • WI State Medical License
    WI State Medical License 1995 - 2005
  • MN State Medical License
    MN State Medical License 1991 - 2004
  • American Board of Medical Genetics and Genomics Clinical Biochemical/Molecular Genetics
  • American Board of Medical Genetics and Genomics Clinical Genetics

Awards, Honors, & Recognition

  • March of Dimes Champion for Babies Award 2015
  • Faculty Honors University of Pittsburgh, 2014
  • Research Educator of the Year Mayo Clinic, 2001
  • Join now to see all

Clinical Trials

Publications & Presentations


Journal Articles

  • DNA methylation in the pathophysiology of hyperphenylalaninemia in the PAH mouse model of phenylketonuria  
    Dobrowolski SF, Lyons-Weiler J, Spridik K, Vockley J, Skvorak K, Biery A, Mol Genet Metab, 1/1/2016
  • Neurometabolic Disorders: Potentially Treatable Abnormalities in Patients With Treatment-Refractory Depression and Suicidal Behavior  
    Pan LA, Martin P, Zimmer T, Segreti AM, Kassiff S, McKain BW, Baca CA, Rengasamy M, Hyland K, Walano N, Steinfeld R, Hughes M, Dobrowolski SK, Pasquino M, Diler R, Per..., American Journal of Psychiatry, 1/1/2016
  • Metformin inhibits Branched Chain Amino Acid (BCAA) derived ketoacidosis and promotes metabolic homeostasis in MSUD  
    Sonnet SD, O' Leary NM, Gutierrez AM, Nguyen MS, Mateen S, Hsu Y, Mitchell PK, Lopez JA, Vockley J, Kennedy K, Ramanathan A, Scientific reports, 1/1/2016
  • Join now to see all

Books/Book Chapters

  • Join now to see all


  • Novel therapies for disorders of fatty acid oxidation 
    Ponte Vedre, FL - 1/1/2016
  • Advances in fatty acid oxidation research 
    Boston, MA - 1/1/2016
  • A Plain Population Genome Project 
    South Bend, IN - 1/1/2016
  • Join now to see all


  • Mitochondrial myopathies. PREP Audio Series 
    Vockley J, Cohen B, and Wang, L-J, American Academy of Pediatrics
  • The acyl-CoA dehydrogenases: Some mechanistic aspects 
    Thorpe C, Schaller RA, Mohsen A-W, Vockley J, University of Calgary Press
    Calgary, Canada - 1/1/1997

Press Mentions

  • Stealth’s Phase III Elamipretide in Mitochondrial Myopathy Has Experts Wary While FDA Approval Debated
    Stealth’s Phase III Elamipretide in Mitochondrial Myopathy Has Experts Wary While FDA Approval DebatedJune 17th, 2019

Hospital Affiliations